This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Nicotine Dependence
and you are
between 18 and 50
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to investigate the use of repetitive transcranial magnetic stimulation (rTMS) to block craving for cigarettes in smokers. rTMS is an investigational procedure, where a device called a "stimulator" provides electricity to a device that creates a magnetic field. This device is placed against the scalp in the front of the head so that the magnetic field is focused on an area of the brain that is thought to be involved in craving for cigarettes. rTMS is an investigational procedure so therefore being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA). Changes in magnetic fields during rTMS administration change electrical currents which may affect brain activity and function.

Provided treatments

  • Device: Active rTMS Condition
  • Device: rTMS Location Control Condition
  • Device: rTMS Frequency Control Condition
Tris trial is registered with FDA with number: NCT00901459. The sponsor of the trial is Duke University and it is looking for 21 volunteers for the current phase.
Official trial title:
A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers